← Change clinical scenario
SELECTED SCENARIO · 02
Established cancer diagnosis
Tumor profiling, liquid biopsy, MRD, neoantigens, or therapy review.
Clinical test selectorStep 2 of 4
- ✓Clinical scenario
- 2Diagnostic objective
- 3Available material
- 4Recommendation
STEP 2
What must the test help answer?
Select the primary diagnostic objective. Alternatives will be shown after the material check.
Comprehensive treatment profiling
Broad DNA biomarkers with tumor–normal comparison.
Focused panel for a known tumor type
Entity-specific genes for common solid tumors.
A fusion or RNA driver is suspected
Known and novel fusion transcripts, MET exon 14, or activating EGFR deletions.
Personalized neoantigen / vaccine design
Tumor–normal exome, RNA, and HLA integration.
Tissue is unavailable or a blood test is preferred
Selected actionable hotspots and fusions in cfDNA.
Monitor residual disease or recurrence
Personalized tumor-informed serial cfDNA monitoring.
Interpret results into treatment options
In-label, off-label, and trial evidence in clinical context.
Cannot define one primary objective?
For complex phenotypes, conflicting previous results, or unclear tumor questions, begin with a case review instead of forcing a selection.
Prepare a case enquiry →